» Veröffentlicht am
15. Mai 2024
New Paper by Sattler and Colleagues on the Prevalence of Legal, Prescription, and Illegal Drugs Aiming at Cognitive Enhancement
Sattler, S., van Veen, F., Hasselhorn, F., El Tabei, L., Fuhr, U.,
& Mehlkop, G. (2024, online first). Prevalence of Legal,
Prescription, and Illegal Drugs Aiming at Cognitive Enhancement
across Sociodemographic Groups in Germany. Deviant Behavior, 1–35.
Abstract
There has been speculation about a growing demand for substances
used without medical need for cognitive enhancement (CE). Thus,
the prevalence rates and the identification of sociodemographic
groups at risk of this behavior need further description and
constant monitoring. We conducted a nationwide web-based
representative sample (N = 22,101) (regarding sex, age,
education, and federal state) of the general adult population in
Germany. Results show a high past twelve months prevalence of
consuming caffeinated drinks for CE (62.4% of respondents),
followed by food supplements and home remedies (31.4%), and
caffeine tablets (2.5%). The twelve-month prevalence of CE with
prescription drugs was 3.7% (lifetime: 5.5%), of whom 29.1%
reported using them 40 or more times; 40.5% of all respondents
indicated some future intake willingness. Cannabis was the most
frequently reported illegal drug for CE (past twelve months: 4.0%;
lifetime: 10.7%), followed by the category amphetamine and
methamphetamine (past twelve months: 1.0%; lifetime: 2.4%), and
cocaine (past twelve months: 0.9; lifetime: 2.4%). We also show
variation in the prevalence across multiple ascribed and achieved
sociodemographic characteristics. These results can inform public
policy and prevention strategies regarding the continued
monitoring of the prevalence of CE and the identification of
groups at risk of drug misuse.
LINK:
https://www.tandfonline.com/doi/full/10.1080/01639625.2024.2334274
»
Weiterlesen